HPV primers

Details HPV primers HPV primers

2007-09-05

2011-12-20

Horlick, Kenneth R. (Department: 1637)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C536S024300, C435S006100

Reexamination Certificate

active

08080643

ABSTRACT:
The present invention provides methods, kits, and compositions related to human papillomavirus (HPV) primers, which may be used, for example, in nucleic acid detection assays for use in basic research, clinical research, and for the development of clinical detection assays.

REFERENCES:
patent: 4551270 (1985-11-01), Danos et al.
patent: 4849331 (1989-07-01), Lorincz
patent: 4849332 (1989-07-01), Lorincz
patent: 4849334 (1989-07-01), Lorincz
patent: 4908306 (1990-03-01), Lorincz
patent: 5057411 (1991-10-01), Lancaster
patent: 5182377 (1993-01-01), Manos
patent: 5283171 (1994-02-01), Manos
patent: 5342930 (1994-08-01), Orth et al.
patent: 5364758 (1994-11-01), Meijer et al.
patent: 5411857 (1995-05-01), Beaudenon et al.
patent: 5447839 (1995-09-01), Bauer
patent: 5484699 (1996-01-01), Bouma
patent: 5501947 (1996-03-01), Emery
patent: 5527898 (1996-06-01), Bauer
patent: 5534439 (1996-07-01), Orth et al.
patent: 5554538 (1996-09-01), Cole et al.
patent: 5580970 (1996-12-01), Hendricks
patent: 5591574 (1997-01-01), Orth et al.
patent: 5614402 (1997-03-01), Dahlberg
patent: 5639871 (1997-06-01), Bauer
patent: 5643715 (1997-07-01), Lancaster
patent: 5648459 (1997-07-01), Cole et al.
patent: 5656423 (1997-08-01), Orth et al.
patent: 5665535 (1997-09-01), Orth et al.
patent: 5665571 (1997-09-01), Beaudenon et al.
patent: 5679509 (1997-10-01), Wheeler
patent: 5681944 (1997-10-01), Crooke
patent: 5705627 (1998-01-01), Manos
patent: 5712092 (1998-01-01), Orth
patent: 5783412 (1998-07-01), Morris
patent: 5795763 (1998-08-01), Dahlberg
patent: 5811232 (1998-09-01), Crooke
patent: 5824466 (1998-10-01), Orth et al.
patent: 5840306 (1998-11-01), Hofmann
patent: 5843669 (1998-12-01), Kaiser
patent: 5846717 (1998-12-01), Brow
patent: 5863717 (1999-01-01), Lancaster
patent: 5876922 (1999-03-01), Orth et al.
patent: 5888724 (1999-03-01), Silverstein
patent: 5952487 (1999-09-01), Philipp et al.
patent: 5958674 (1999-09-01), Beaudenon et al.
patent: 5981173 (1999-11-01), Orth et al.
patent: 5985557 (1999-11-01), Prudent
patent: 5994069 (1999-11-01), Hall
patent: 6001567 (1999-12-01), Brow
patent: 6001983 (1999-12-01), Benner
patent: 6045993 (2000-04-01), Mahony
patent: 6090543 (2000-07-01), Prudent
patent: 6107086 (2000-08-01), Cole et al.
patent: 6117634 (2000-09-01), Langmore
patent: 6127164 (2000-10-01), de Villiers et al.
patent: 6159729 (2000-12-01), Hofmann et al.
patent: 6183960 (2001-02-01), Lizardi
patent: 6194149 (2001-02-01), Neri
patent: 6197557 (2001-03-01), Makarov
patent: 6210884 (2001-04-01), Lizardi
patent: 6218104 (2001-04-01), Morris
patent: 6228577 (2001-05-01), Mahony
patent: 6235502 (2001-05-01), Weissman
patent: 6242250 (2001-06-01), Cole
patent: 6265154 (2001-07-01), Kroeger
patent: 6344314 (2002-02-01), Cole et al.
patent: 6352825 (2002-03-01), Meijer et al.
patent: 6420106 (2002-07-01), Gyllensten
patent: 6458940 (2002-10-01), Robert
patent: 6482588 (2002-11-01), Van Doorn et al.
patent: 6503704 (2003-01-01), Mahony
patent: 6509149 (2003-01-01), Roberts
patent: 6511805 (2003-01-01), Gocke
patent: 6583278 (2003-06-01), Carter
patent: 6613557 (2003-09-01), Frazer
patent: 6649167 (2003-11-01), Hallek
patent: 6827933 (2004-12-01), Orth et al.
patent: 6858412 (2005-02-01), Willis et al.
patent: 7195871 (2007-03-01), Lyamichev et al.
patent: 2002/0155427 (2002-10-01), Cohenford et al.
patent: 2003/0152942 (2003-08-01), Fors et al.
patent: 2004/0170982 (2004-09-01), Morris et al.
Lorincz et al. Cloning and partial DNA sequencing of two new human papillomavirus types associated with condylomas and low-grade cervical neoplasia. J. Virol. (1989) vol. 63, No. 6, pp. 2829-2834.
Lorincz et al. Human papillomavirus type 43 complete genome. (2005) GenBank accession No. AJ620205.
Schweitzer, et al. “Hydrophobic, Non-Hydrogen-Bonding Bases and Base Pairs in DNA” J. Am. Chem. Soc., 1995, 117, 1863-1872.
Vernon, et al. “Bioelectric DNA detection of human papillomaviruses using eSensor: a model system for detection of multiple pathogens” BMC Infectious Diseases, vol. 3: 12 pp. 1-9, Jun. 2003.
Wallboomers, et al. “Human papillomavirus is a necessary cause of invasive cervical cancer worldwide” 1999 J Pathol. 189 pp. 12-19.
Wright, et al. “2001 Consensus Guidelines for the management of women with cervical cytological abnormalities” JAMA, vol. 287 pp. 2120-2129 (2002).
Wright, et al. “Adding a test for human papillomavirus DNA to cervical-cancer screening.” 2003 Engl. J. Med. 348 pp. 489-490.
Wright, et al. “HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer” JAMA, vol. 283, pp. 81-86 (2000).
Allawi, et al. “Thermodynamics and NMR of internal G.T mismatches in DNA” Biochemistry 36, 10581-94 (1997).
Anderson, et al. “Quantitative Filter Hybridization” in Nucleic Acid Hybridization, pp. 73-111 (1985).
Bosch, et al. “The casual relation between human papillomavirus and cervical cancer” J Clin. Pathol. 2002; 55:244-65.
Burd, et al. “Human papillomavirus and cervical cancer.” 2003 Clin Microbiol Rev. 16 pp. 1-17.
Campo, et al. Molecular Cloning of Bovine Papillomavirus Genomes and Comparison of Their Sequence Homologies by Heteroduplex Mapping. J. gen. Virol. (1982), 63, 255-264.
Clavel, et al. “Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women” 2001. Br J Cancer, vol. 84, pp. 1616-1623.
Coggins, et al. “The Genomes of Bovine Papillomaviruses Types 3 and 4 are Colinear” J. gen. Viral. (1983), 64, 2771-2776.
Crum, et al. “Human Papillomavirus Type 16 and Early Cervical Neoplasia. The New England Journal of Medicine” Apr. 1984; 310(14):880-883.
Danos, et al. “Molecular Cloning, Refined Physical Map and Heterogeneity of Methylation Sites of Papilloma Virus Type 1a DNA” Eur. J. Biochem. (1980),109,457-461.
Doty, et al. “Strand Separation and Specific Recombination in Deoxyribonucleic Acids: Physical Chemical Studies” Proc. Natl. Acad. Sci. USA 46:461-76 (1960).
Fahey, et al. “Meta-analysis of Pap test accuracy” Am J Epidemiol. 1995;141:680-9.
Franco, et al. “Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection” CMAJ, vol. 164, pp. 1017-1025 (2001).
Gissmann “Human Papillomavirus DNA in Genital Tumours” IARC Sci. Publ. 1984, 63, 405-411.
Gissmann, et al. Presence of Human Papillomavirus in Genital Tumors. The Journal of Investigative Dermatology. (1984), 83, 26s-28s.
Gravitt, et al. “Improved amplification of genital human papillomaviruses” 2000 J. Clin. Microbiol. 38(1) pp. 357-361.
Hall, et al. “Sensitive detection of DNA polymorphisms by the serial invasive signal amplification reaction.” 2000 PNAS USA 97 pp. 8272.
Howley “The Human Papillomaviruses” Arch Pathol Lab Med. (1982), 106,429-432.
Hutchinson, et al. “Utility of liquid-based cytology for cervical carcinoma screening: results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma” 1999, Cancer, vol. 87, pp. 48-55.
Hybrid Capture II (HCII) test, Digene, Gaithersburg, MD, (2007).
Ikenberg, et al. “Human Papillomavirus Type-16-Related DNA in Genital Bowen's Disease and in Bowenoid Papulosis” Int. J. Cancer. (1983), 32, 563-565.
Kleter, et al. “Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus” Journal of Clinical Microbiology, vol. 37, No. 8, pp. 2508-2517, Aug. 1999.
Kong, et al. “Synthesis and duplex stability of oligonucleotides containing cytosine-thymine analogues” Nucleic Acids Res., 1989, 17, 10373-10383.
Kong, et al. “Synthesis of oligodeoxyribonucleotides containing degenerate bases and their use as primers in the polymerase chain reaction” Nucleic

Affiliated with

Also associated with

Rating

HPV primers does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with HPV primers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HPV primers will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4264615